Although 24 weeks of dulaglutide (3 g/day) treatment in obese elderly patients with diabetes did not show an exacerbation of sarcopenia parameters [90], it is unlikely that GLP-1 RAs improve sarcopenia. The gene discussed is GCG; the disease is sarcopenia.